Nanotechnology Drug Delivery Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Nanotechnology Drug Delivery Market
Nanotechnology Drug Delivery Market: By Technology (Nanocrystals, Nanoparticles, Others), By Application (Neurology, Oncology, Anti-infective, Others) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0300
Updated Date: 16 May, 2018  

1. Nanotechnology Drug Delivery Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Nanotechnology Drug Delivery Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Expanding nanotechnology research
      4.1.3. Rising demand for novel drug delivery
   4.2. Restraints
      4.2.1. High cost of production
      4.2.2. Stringent regulatory scenario
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Nanotechnology Drug Delivery Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Nanotechnology Drug Delivery Market, By Technology
   6.1. Nanocrystals
   6.2. Nanoparticles
   6.3. Liposomes
   6.4. Micelles
   6.5. Nanotubes
   6.6. Others
7. Nanotechnology Drug Delivery Market, By Application
   7.1. Neurology
   7.2. Oncology
   7.3. Cardiovascular/Physiology
   7.4. Anti-inflammatory/Immunology
   7.5. Anti-infective,
   7.6. Others
8. Nanotechnology Drug Delivery Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Nanotechnology Drug Delivery – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. AbbVie, Inc
   10.2. Amgen, Inc
   10.3. Celgene Corporation
   10.4. Johnson & Johnson
   10.5. Merck & Co., Inc
   10.6. Novartis International AG
   10.7. 3M company
   10.8. AMSC Corporation
   10.9. Agilent Technologies Inc
   10.10. Bayer AG.
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll